The bovine diagnostics market was valued at US$ 1,155.59 million in 2022 and is expected to reach US$ 2,011.15 million by 2030. It is estimated to register a CAGR of 7.2% during 2022–2030. The upsurge in research funding to develop modern diagnostic approaches is likely to remain a key bovine diagnostics market trend.

Bovine Diagnostics Market Analysis

Bovine refers to a domestic animal such as cattle, buffalo, goat, and sheep. The growth of the market is attributed to the increasing  prevalence and economic impact of bovine mastitis and increasing number of product launches by major manufacturers. However, lack of skilled professionals in animal research sector may hinders the market growth.

Bovine Diagnostics Market Overview

Bovine mastitis is a major concern that incurs economic losses to the global agriculture sector. Mastitis diseases to the bovine species animals results in lowered milk production that inlead resulting in reduced profitability for dairy farmers. According to the study published “Global and countrywide prevalence of clinical mastitis and subclinical in dairy cattle and buffaloes by systematic review and meta-analysis,” published in April 2021, the worldwide prevalence of subclinical mastitis and clinical mastitis were about 42% and 15%, respectively, during the year 2011–2019. In India, the prevalence of subclinical mastitis and clinical mastitis were 45% and 18%, respectively, during the forecast period. The study also reported that North America and Europe had a higher prevalence of subclinical mastitis, while countries such as the Uganda and UK had a higher prevalence of clinical mastitis. The prevalence of overall mastitis is expected to increase due to the prolonged history of the diseases in the dairy industry. Moreover, surveillance programs and proper management systems introduced by governments in different countries support the growth of the bovine diagnostics market. The factors mentioned above are influences the growth of the bovine diagnostics market.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Bovine Diagnostics Market: Strategic Insights

Bovine Diagnostics Market

• 
  CAGR (2023 - 2031)

  7.20%
• Market Size 2023
  US$ 1.22 Billion
• Market Size 2031
  US$ 2.01 Billion

Market Dynamics

GROWTH DRIVERS

• High Prevalence And Good Management Systems Introduced By Governments In Different Countries Support The Bovine Diagnostics Market.

FUTURE TRENDS

• Increasing Prevalence of Bovine Tuberculosis

OPPORTUNITIES

• Upsurge in Research Funding to Develop Modern Diagnostic Approaches

Key Players

• Idexx Laboratories Inc.
• PBD Biotech Ltd
• Thermo Fisher Scientific Inc.
• Innovative Diagnostics SAS
• Neogen Corp
• Enfer Labs
• bioMerieux SA
• Ring Biotechnology Co Ltd
• Bionote Inc.
• Shenzhen Bioeasy Biotechnology Co Ltd

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Product

• Immunoassay Kits
• PCR Reagents & Kits
• Hemagglutination Inhibition

Disease Type

• Bovine Viral Diarrhea

End User

• Veterinary Hospitals
• Veterinary Clinics
• Other End Users

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Bovine Diagnostics Market Drivers and Opportunities

Increasing Number of Product Launches Favors Market

Rapid research and development activities allow veterinary diagnostics prominent companies to launch various innovative diagnostics products that provide rapid output for diagnosis. In addition, growing awareness among end users via the government’s educative and knowledge-sharing programs and initiatives has encouraged these companies to launch advanced diagnostics products. A few of the new product launches in the bovine diagnostics market are, for instance,  in June 2023, Zoetis, Inc. company launched Vetscan Mastigram+, an on-farm mastitis diagnostic solution that offers results eight hours before the next milking cycle. The Vetsacn Mastigram+ uses a flow dipstick test for detection of Gram-positive mastitis in cattle. The product will also help in detecting the presence of Gram-positive pathogens in cow milk with 99% sensitivity as well as 100% specificity, along with differentiating between Gram-positive and Gram-negative bacteria.

High Prevalence of Bovine Tuberculosis – An Opportunity in Bovine Diagnostics Market

Bovine tuberculosis (bTB) is a type of chronic infectious disease that affects cattle and is later transferred to other animals and humans. The World Organization for Animal Health (WOAH) has listed bTB and must be detected and reported as soon as possible. As per the report shared by Thermo Fisher Scientific company in May 2023, bTB affects more than 50 million cattle globally, incurring annual economic losses of around US$ 3 billion. In the UK, bTB disease incurs financial losses of  about US$ 145 million annually.

The diseases casing rate of bTB differs in different geographic areas. It is rare in Canada, Europe, , and the US. However, bovine tuberculosis is around 50% in Africa and some parts of Asian countries. Although ongoing technological and infrastructural developments, still many developing countries fail to effectively diagnose bTB due to the complexity as well as the lack of universal strategies for its diagnosis. This scenario provides opportunities for bovine diagnostics market players to enhance awareness in Africa and Asia and launch new products that suit the socioeconomic conditions in these countries.

Bovine Diagnostics Market Report Segmentation Analysis

Key segments that contributed to the derivation of the bovine diagnostics market analysis are product, disease type, and end user.

• Based on product, the bovine diagnostics market is divided into Immunoassay Kits, PCR Reagents & Kits, Hemagglutination Inhibition (HI) Assay, and Other Products. The Immunoassay Kits segment held a higher market share in 2022.
•  Based on disease type, the market is segmented into Bovine Viral Diarrhea (BVD), Bovine Tuberculosis (TB), Bovine Mastitis, Foot and Mouth Disease (FMD), and  Other Disease Types.
• In terms of end users, the market is segmented into Veterinary Hospitals, Veterinary Clinics, and Other End-Users.

Bovine Diagnostics Market Share Analysis by Geography

The geographic scope of the bovine diagnostics market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

In North America, the bovine diagnostics market is currently in exponential growth during the forecast years. The US dominated the market in 2022. The bovine diagnostics market in the US has benefitted from rising government initiatives to control mastitis, zoonotic diseases,  and tuberculosis diseases. Continuous research and developments in veterinary diagnostics resulting in bovine diagnostics new product launches. For instance, in October 2022, the Kansas State Veterinary Diagnostic Laboratory of the State University College of Veterinary Medicine developed test  kit to detect two major blood-borne diseases in cattle. Researcher team at Kansas State Veterinary Diagnostic Laboratory developed a PCR diagnosis technique to detect endemic anaplasmosis and emerging Theileriosis. The test will allow cattle farmers and veterinarians to diagnose herds with disease-causing microorganisms and also help them effectively prevent and manage the veterinary diseases.

Bovine Diagnostics Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Bovine Diagnostics Market News and Recent Developments

The bovine diagnostics market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for innovations, business expansion, and strategies:

• In July 2023, PBD Biotech and Actiphage TB entered its third clinical trial. A ground-breaking phage-based molecular diagnostic has been agreed between its developer, PBD Biotech, the NIHR Respiratory Biomedical Research Centre, Leicester (UK)and University of Leicester. The study aims to validate the test's utility as a tuberculosis diagnostic. The phage-based diagnostic has the potential to detect TB progression. (Source: PBD Biotech and Actiphage TB Press Release)

Bovine Diagnostics Market Report Coverage and Deliverables

The “Bovine Diagnostics Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering the following areas:

• Bovine Diagnostics Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Bovine Diagnostics Market trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Bovine Diagnostics market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
• Bovine Diagnostics Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles